Julieta Oribe Bubica*, Sergio Gabriel Montañez, Bibiana Beatriz Ruiz and Gerardo Enzo Castro Ocampo
To arrive at the diagnosis of certain inflammatory bowel diseases and establish the severity of the picture, invasive approach is routinely used for the patient through colonoscopy, contrast radiography, among others. Due to the logical resistance generated by submitting to practices of this type and considering that it is difficult to harmonize clinical, endoscopic and histological result, it was imperative to have a marker that would be part of a noninvasive test and as objective as possible and reproducible for evaluate this type of pathology.
